Small artery remodeling is the most prevalent (earliest?) form of target organ damage in mild essential hypertension

Background The heart and blood vessels are exposed to elevated blood pressure (BP) in hypertensive patients, but their changes in response to BP or non-hemodynamic stimuli may be different, and occur with different time-courses. To evaluate this, we studied the prevalence of structural and functional alterations of resistance arteries and cardiac hypertrophy in patients with mild essential hypertension. Methods Resistance arteries were dissected from gluteal subcutaneous tissue from 38 hypertensive patients (47 ± 1 years; 71% male; BP 148 ± 2/99 ± mmHg), studied on a pressurized myograph, and compared to those from 10 normotensives (44 ± 3 years; 40% male; BP 113 ± 4/76 ± 2 mmHg). Results The prevalence of abnormal structure (media-to-lumen ratio, M/L) and impaired endothelial function (maximal acetylcholine response) was 97 and 58% (abnormal was defined as greater than mean + 1SD of normotensives), or 63 and 34% (abnormal defined as greater than mean + 2SD). Thirty four percent of hypertensive patients exhibited left ventricular hypertrophy by echocardiography. When grouped into tertiles according to increasing ambulatory systolic BP (SBP), the highest BP tertile showed increased M/L (P < 0.01) and left ventricular mass index (LVMI, P < 0.05) and marginally decreased endothelial function (P = 0.07). LVMI was greatest in the tertile of patients with highest M/L (P < 0.05). Endothelial function was decreased in the tertile with greatest vascular stiffness (P < 0.01). By multivariate analysis, M/L correlated with ambulatory SBP (β = 0.40, P = 0.02), and LVMI correlated with ambulatory SBP (β = 0.41, P = 0.001) and body mass index (β = 0.30, P < 0.05). Female sex influenced endothelial function negatively (β =− 0.63, P < 0.01). Conclusion Structural alterations of resistance arteries were demonstrated in most hypertensive patients, followed by endothelial dysfunction and cardiac hypertrophy in a smaller number of hypertensives. Small artery structural remodeling may precede most clinically relevant manifestations of target organ damage in mild essential hypertension.

[1]  E. Schiffrin,et al.  Correlation of endothelial function in large and small arteries in human essential hypertension. , 2001, Journal of hypertension.

[2]  E. Schiffrin,et al.  Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. , 2000, Circulation.

[3]  S. Higano,et al.  Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. , 2000, Circulation.

[4]  E. Schiffrin,et al.  System Journal of Renin-angiotensin-aldosterone Journal of Renin-angiotensin-aldosterone System Essential Hypertension Reduction of Resistance Artery Stiffness by Treatment with the At1-receptor Antagonist Losartan in Journal of Renin-angiotensin-aldosterone System Additional Services and Informatio , 2022 .

[5]  R. Cannon,et al.  Vascular effects of estrogen and vitamin E therapies in postmenopausal women. , 1999, Circulation.

[6]  M. O'Rourke,et al.  Pulse pressure: Is this a clinically useful risk factor? , 1999, Hypertension.

[7]  E. Schiffrin,et al.  Relationship between small-artery structure and systolic, diastolic and pulse pressure in essential hypertension. , 1999, Journal of hypertension.

[8]  E. Schiffrin,et al.  Mechanics and composition of human subcutaneous resistance arteries in essential hypertension. , 1999, Hypertension.

[9]  P. Ganz,et al.  Estradiol therapy combined with progesterone and endothelium-dependent vasodilation in postmenopausal women. , 1998, Circulation.

[10]  E. Schiffrin,et al.  Apoptosis in vasculature of spontaneously hypertensive rats: effect of an angiotensin converting enzyme inhibitor and a calcium channel antagonist. , 1998, American journal of hypertension.

[11]  K. Kanmatsuse,et al.  [Pathogenesis of acute coronary syndromes]. , 1998, Nihon rinsho. Japanese journal of clinical medicine.

[12]  M. Safar,et al.  Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. , 1998, Hypertension.

[13]  Giuseppe Mancia,et al.  Risk factors associated with alterations in carotid intima—media thickness in hypertension: baseline data from the European Lacidipine Study on Atherosclerosis , 1998, Journal of hypertension.

[14]  M. Omata,et al.  Ostensible day-night difference of QT prolongation during long-term treatment with antiarrhythmic drugs: reappraisal of the law of "regression to the mean". , 1998, Journal of cardiovascular pharmacology.

[15]  V. Miller,et al.  The Effect of Estrogen Replacement Therapy on Plasma Nitric Oxide and Endothelin-1 Levels in Postmenopausal Women , 1998, Annals of Internal Medicine.

[16]  T. Koob,et al.  Contribution of chondroitin-dermatan sulfate-containing proteoglycans to the function of rat mesenteric arteries. , 1997, The American journal of physiology.

[17]  A. Heagerty,et al.  Blood pressure parameters as determinants of small artery structure in human essential hypertension. , 1997, Clinical science.

[18]  D. Hayoz,et al.  Time course changes of the mechanical properties of the carotid artery in renal hypertensive rats. , 1997, Hypertension.

[19]  Detection.  The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) , 1997 .

[20]  J. Mallion,et al.  Left ventricular hypertrophy and arterial hypertrophy. , 1997, Advances in experimental medicine and biology.

[21]  M. Mulvany,et al.  Some pharmacological and elastic characteristics of isolated subcutaneous small arteries from patients with essential hypertension , 1996, Journal of hypertension.

[22]  E. Schiffrin,et al.  Effect of calcium channel blockade or angiotensin-converting enzyme inhibition on structure of coronary, renal, and other small arteries in spontaneously hypertensive rats. , 1996, Journal of cardiovascular pharmacology.

[23]  B. Strauer,et al.  Improvement of coronary flow reserve after long-term therapy with enalapril. , 1996, Hypertension.

[24]  M. Creager,et al.  Aging progressively impairs endothelium-dependent vasodilation in forearm resistance vessels of humans. , 1996, Hypertension.

[25]  T. Lüscher,et al.  Direct in situ measurement of nitric oxide in mesenteric resistance arteries. Increased decomposition by superoxide in hypertension. , 1996, Hypertension.

[26]  B. Folkow.  Hypertensive structural changes in systemic precapillary resistance vessels: how important are they for in vivo haemodynamics? , 1995, Journal of hypertension.

[27]  A. Yeung,et al.  Close relation of endothelial function in the human coronary and peripheral circulations. , 1995, Journal of the American College of Cardiology.

[28]  R. Wilson,et al.  Direct effects of smooth muscle relaxation and contraction on in vivo human brachial artery elastic properties. , 1995, Circulation research.

[29]  J. Schwartz,et al.  Prevalence and determinants of cardiac and vascular hypertrophy in hypertension. , 1995, Hypertension.

[30]  E. Schiffrin,et al.  Endothelium-dependent relaxation of small arteries from essential hypertensive patients: mechanisms and comparison with normotensive subjects and with responses of vessels from spontaneously hypertensive rats. , 1995, Clinical science.

[31]  A. Izzard,et al.  Hypertension and the vasculature: arterioles and the myogenic response , 1995, Journal of hypertension.

[32]  D. Spiegelhalter,et al.  Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. , 1994, Journal of the American College of Cardiology.

[33]  J. Ritter,et al.  Preserved endothelium-dependent vasodilatation in patients with essential hypertension. , 1994, The New England journal of medicine.

[34]  S. Kaul,et al.  Functional improvement precedes structural regression of atherosclerosis. , 1994, Circulation.

[35]  E. Porteri,et al.  Vascular structural and functional alterations before and after the development of hypertension in SHR. , 1994, American journal of hypertension.

[36]  E. Schiffrin,et al.  Effects of a beta-blocker or a converting enzyme inhibitor on resistance arteries in essential hypertension. , 1994, Hypertension.

[37]  M. Mulvany,et al.  Histology of subcutaneous small arteries from patients with essential hypertension. , 1993, Hypertension.

[38]  E. Schiffrin,et al.  Morphology of resistance arteries and comparison of effects of vasoconstrictors in mild essential hypertensive patients. , 1993, Clinical and investigative medicine. Medecine clinique et experimentale.

[39]  M. Mulvany,et al.  Small artery structure in hypertension. Dual processes of remodeling and growth. , 1993, Hypertension.

[40]  M. Mulvany,et al.  Mesenteric arcade arteries contribute substantially to vascular resistance in conscious rats. , 1993, Journal of Vascular Research.

[41]  V. Fuster,et al.  The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.

[42]  M. Mulvany,et al.  Structure and function of small arteries. , 1990, Physiological reviews.

[43]  A. Quyyumi,et al.  Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. , 1990, The New England journal of medicine.

[44]  R. Bonow,et al.  Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. , 1988, The New England journal of medicine.

[45]  A. Heagerty,et al.  Evidence for increased media thickness, increased neuronal amine uptake, and depressed excitation--contraction coupling in isolated resistance vessels from essential hypertensives. , 1987, Circulation research.

[46]  O. Carretero,et al.  The Loss of Endothelium‐Dependent Vascular Relaxation in Hypertension , 1986, Hypertension.

[47]  N. Reichek,et al.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. , 1986, The American journal of cardiology.

[48]  B. Folkow.  Physiological aspects of primary hypertension. , 1982, Physiological reviews.